Perspectives in AML treatment: targeting apoptosis without chemotherapy by using BH3-mimetics
The 20th anniversary of the German CLL Study Group and the importance of collaboration
Treatment at first relapse in multiple myeloma: how to choose a drug?
Can maintenance therapy improve patient outcome?
Mathias J Rummel
HSV-TK cells as adjunctive treatment for haplo-HSCT